HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sang Geon Kim Selected Research

rat Cyp3a23-3a1 protein

6/2003Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats.
12/2002Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sang Geon Kim Research Topics

Disease

39Neoplasms (Cancer)
01/2022 - 01/2002
14Fibrosis (Cirrhosis)
01/2022 - 01/2002
13Liver Diseases (Liver Disease)
01/2022 - 01/2004
10Inflammation (Inflammations)
10/2021 - 10/2002
9Insulin Resistance
10/2020 - 09/2007
8Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2009
8Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 01/2002
7Carcinogenesis
03/2010 - 05/2002
6Body Weight (Weight, Body)
02/2020 - 01/2002
5Wounds and Injuries (Trauma)
10/2017 - 05/2005
5Hypoxia (Hypoxemia)
01/2016 - 10/2009
5Necrosis
11/2015 - 06/2005
5Acute Kidney Injury (Acute Renal Failure)
11/2014 - 06/2002
5Protein-Energy Malnutrition (Marasmus)
07/2003 - 02/2002
4Fatty Liver
12/2018 - 03/2011
4Hepatitis
10/2017 - 06/2005
4Ascites
06/2016 - 12/2002
4Neoplasm Metastasis (Metastasis)
02/2015 - 01/2008
3Drug-Related Side Effects and Adverse Reactions
02/2020 - 01/2007
3Hyperbilirubinemia
10/2017 - 01/2008
2Liver Neoplasms (Liver Cancer)
01/2022 - 11/2020
2Breast Neoplasms (Breast Cancer)
11/2020 - 11/2006
2Non-alcoholic Fatty Liver Disease
11/2018 - 10/2011
2Metabolic Diseases (Metabolic Disease)
12/2015 - 01/2010
2Hyperplasia
04/2011 - 07/2010
2Thrombosis (Thrombus)
01/2007 - 09/2006
2Renal Insufficiency (Renal Failure)
12/2002 - 06/2002

Drug/Important Bio-Agent (IBA)

18oltiprazIBA
04/2013 - 01/2002
11Proteins (Proteins, Gene)FDA Link
10/2021 - 02/2002
10MicroRNAs (MicroRNA)IBA
01/2019 - 03/2012
10Pharmaceutical PreparationsIBA
03/2014 - 10/2002
6Cytochrome P-450 CYP2E1 (CYP2E1)IBA
11/2006 - 06/2002
5Glucose (Dextrose)FDA LinkGeneric
01/2020 - 11/2006
5Messenger RNA (mRNA)IBA
12/2019 - 11/2006
5Alanine Transaminase (SGPT)IBA
10/2017 - 01/2002
5CCAAT-Enhancer-Binding Protein-betaIBA
04/2009 - 02/2005
4EnzymesIBA
11/2020 - 05/2002
4AntioxidantsIBA
06/2014 - 02/2010
4DDBIBA
11/2012 - 10/2002
4Phosphotransferases (Kinase)IBA
07/2012 - 09/2007
4Insulin (Novolin)FDA Link
03/2012 - 09/2007
4IronIBA
02/2012 - 01/2009
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2009 - 01/2002
4Glutathione Transferase (Glutathione S-Transferase)IBA
10/2007 - 05/2004
4Uranyl NitrateIBA
06/2003 - 06/2002
3Cadherins (E-Cadherin)IBA
12/2019 - 12/2010
3BilirubinIBA
10/2017 - 01/2002
3Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2016 - 04/2010
3Liver X ReceptorsIBA
04/2013 - 06/2009
3Adenosine Monophosphate (AMP)IBA
08/2010 - 09/2007
3AMP-Activated Protein KinasesIBA
10/2009 - 05/2008
3ThionesIBA
10/2009 - 01/2002
3Glutathione (Reduced Glutathione)IBA
04/2007 - 03/2003
3Cytochrome P-450 CYP1A2 (CYP1A2)IBA
09/2005 - 12/2002
2Acetaminophen (Paracetamol)FDA LinkGeneric
01/2022 - 06/2006
2Transcription Factors (Transcription Factor)IBA
11/2020 - 01/2016
2CytokinesIBA
10/2020 - 10/2003
2NitrogenIBA
10/2020 - 06/2002
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020 - 01/2018
2Biomarkers (Surrogate Marker)IBA
10/2019 - 10/2011
2Sirtuin 1IBA
12/2018 - 03/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018 - 10/2009
2LigandsIBA
01/2018 - 01/2018
2Biological ProductsIBA
01/2016 - 04/2013
2Transaminases (Aminotransferases)IBA
04/2015 - 11/2012
2protoporphyrin IXIBA
02/2015 - 06/2013
2Superoxides (Superoxide)IBA
06/2014 - 10/2009
2PorphyrinsIBA
06/2013 - 02/2012
2FlavonoidsIBA
12/2012 - 03/2003
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2012 - 01/2002
2dimethyl- 4,4'- dimethoxy- 5,6,5',6'- dimethylene dioxybiphenyl-2,2'-dicarboxylateIBA
11/2012 - 06/2005
2allyl sulfideIBA
11/2012 - 06/2005
2Toll-Like Receptors (Toll-Like Receptor)IBA
08/2012 - 06/2011
2Epoxide HydrolasesIBA
06/2012 - 05/2002
2Small Interfering RNA (siRNA)IBA
03/2012 - 10/2009
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2012 - 10/2009
2LipidsIBA
07/2011 - 03/2011
2CollagenIBA
05/2011 - 10/2002
2Protein Kinases (Protein Kinase)IBA
08/2010 - 06/2009
2Glycogen Synthase Kinase 3 betaIBA
05/2010 - 10/2009
21,2-dithiol-3-thioneIBA
01/2009 - 05/2008
2TransferasesIBA
04/2007 - 03/2003
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2007 - 06/2004
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2007 - 12/2002
2hydroxide ionIBA
11/2006 - 06/2003
2AcidsIBA
06/2006 - 12/2002
2Aminophylline (Carine)FDA LinkGeneric
09/2005 - 12/2002
2Theophylline (Theon)FDA LinkGeneric
09/2005 - 12/2002
21,3-dimethyluric acidIBA
09/2005 - 12/2002
2dithiolIBA
09/2005 - 01/2002
2Transforming Growth Factor beta1 (TGF beta 1)IBA
05/2005 - 01/2002
2Serum AlbuminIBA
02/2005 - 01/2004
2XenobioticsIBA
11/2003 - 05/2002
2ChlorzoxazoneFDA LinkGeneric
06/2003 - 06/2003
2rat Cyp3a23-3a1 proteinIBA
06/2003 - 12/2002
2Cytochrome P-450 CYP2B1 (PROD)IBA
06/2003 - 12/2002
2Cysteine (L-Cysteine)FDA Link
04/2003 - 02/2002

Therapy/Procedure

10Therapeutics
11/2020 - 01/2010
3Oral Administration
11/2014 - 09/2005
3Intravenous Administration
11/2006 - 12/2002